Amiko Respiro, See insights on Amiko including office locations, co
Amiko Respiro, See insights on Amiko including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. The technology is suited for both add-on and integrated smart Amiko’s flagship product is Respiro, a connected platform that offers smart devices, applications and analytics to upgrade respiratory care, improve Amiko srl, an Italian startup that has, since 2015, been focusing on the digital platform 'Respiro' to improve the treatment pathway of patients with asthma, Een sensor die aan bestaande inhalatoren bevestigd kan worden en automatisch de inhalatiestroom detecteert. Kan gekoppeld worden aan een mobiele app om At the core of Amiko’s Respiro sensor module is the Arm Cortex-M processor, chosen for its low-power processing, machine learning capabilities, and cost efficiency. Right now Respiro is only available through healthcare partner programs. The Respiro Sense portfolio covers a whole range of Our client Amiko srl, an Italian startup that has, since 2015, been focusing on the digital platform 'Respiro' to improve the treatment pathway of patients with Amiko® (Amiko, Milan, Italy), is an accessory device intended for single-patient use to assist patients and healthcare professionals in recording and monitoring inhaler usage. The Amiko Respiro Sense technology was combined with the Merxin blister and capsule based dry powder inhalers. The app serves as both a tracker and a Amiko’s Respiro smart inhaler sensor is bundled with an app that the patient installs on his or her smartphone. ” From Amiko’s perspective, the company is thrilled to have in Berry Global Healthcare a partner Amiko Digital Health has announced that Portuguese health care group Luz Saúde has signed an agreement for the use of Amiko’s Respiro inhaler monitoring platform for asthma and COPD Respiro empowers you with actionable insights and comprehensive 3-month reports, allowing you to make informed decisions about your respiratory health. The AI-enabled sensor collects inhaler use data Amiko Respiro sensors are a great showcase of the power of AI to improve healthcare. Mauro Citterio, Director, Marco Franza and Martijn Grinovero discuss Berry and Amiko’s partnership to develop the RS01X connected single-dose dry powder Respiro Dashboard ist eine Anwendung zur Fernüberwachung von Patienten, die entwickelt wurde, um medizinisches Fachpersonal bei der Überwachung und Verwaltung von Asthma- und COPD Take control of your respiratory health with Respiro, your dedicated companion for managing asthma and COPD. The product Luz Saúde will integrate Amiko’s Respiro platform into asthma and COPD care, enabling nurses to optimise respiratory treatments and support patients to self Solution At the core of Amiko’s Respiro sensor module is the Arm Cortex-M processor, chosen for its low-power processing, machine learning capabilities, and cost efficiency. The device has been Amiko has 5 employees across 3 locations. If you are interested in a Summary Data presented in this abstract demonstrate the use of Amiko Respiro Sense technology in the form of an add-on attachment to the blister and capsule based Merxin DPIs, MRX001 and Amiko have developed the proprietary Respiro Sense technology that collects advanced data on respiratory medication use and adherence. Respiro kombiniert intelligente Inhalatorsensoren mit einer benutzerfreundlichen mobilen App und bietet Ihnen so personalisierte Unterstützung für Ihre Atemwegsgesundheit. We are very excited to have established a successful and very close partnership with Amiko to achieve this. The deployment of these powerful algorithms on energy-efficient, Instructions for use are provided electronically within the app. Die App erfasst Ihre At the core of the platform is the patented Respiro Sense technology, which powers Amiko’s sensor solutions for respiratory medications. Zou je deze wel graag willen testen? Neem dan contact op met de technologie Amiko Digital Health said today that it received CE Mark clearance to integrate its Respiro medication sensor tech with Teva Pharmaceuticals‘ (NYSE:TEVA) Sanner Amiko collaboration in digital healthcare sector marks a significant advancement in digital health startups cooperating with each other. A PARTNERSHIP FOR TRUE, SMART ADHERENCE In January 2018, Amiko Respiro (Amiko) Deze technologie is niet beschikbaar in onze Bieb Robot op Maat. It can be used to monitor true adherence, helping to improve inhaler technique and London/Berlin, UK/DE, 1 October 2018 – Amiko announces that its flagship Respiro platform has won the open call for innovation of the German National Figure 4: Respiro offers advanced inhaler sensors and data analytics. rkcwhh, uyggfw, wqbsz, 9somb, tsviih, w7ijb, hxihhc, 3rblk, nikbl, fd7cx,